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Staphylococcus aureus䌤
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The expression of virulence factors in Staphylococcus aureus is tightly coordinated by a vast network of
regulatory molecules. In this report, we characterize a genetic locus unique to staphylococci called rsr that has
a role in repressing two key virulence regulators, sarR and agr. Using strain SH1000, we showed that the
transcription of virulence effectors, such as hla, sspA, and spa, is altered in an rsr mutant in a way consistent
with agr upregulation. Analysis of RNAIII expression of the agr locus in rsr and rsr-sarR mutants indicated that
rsr likely contributes to agr expression independently of SarR. We also provide evidence using a murine model
of S. aureus skin infection that the effects mediated by rsr reduce disease progression.
(SarA, MgrA, ArlRS, SrrAB, SarX, and SarR) have been described, some with positive effects (e.g., SarA and MgrA) and
others with negative effects (e.g., SrrAB and SarX) (7, 10, 15,
19, 20, 27).
Lying adjacent to sarR, which encodes a 13.6-kDa protein
belonging to the SarA family of DNA binding global regulators
in the S. aureus chromosome (6), is a gene we called rsr (for
repressor of sarR) that is associated with sarR expression. We
also confirmed that rsr is a repressor of the agr system. Additionally, an rsr mutant is hypervirulent in a murine model of
skin infection. These data suggest that the rsr locus is a general
inhibitor of virulence in S. aureus.

Staphylococcus aureus is a leading cause of hospital- and
community-acquired infections in the United States (8, 18). Its
ability to colonize a variety of sites gives rise to a number of
disease states ranging from superficial skin and soft tissue
infections to pneumonia, endocarditis, osteomyelitis, and septic shock. Disease progression and severity are mediated by a
diverse array of cell adhesion molecules, toxins, and immune
system modulators which are tightly controlled by a large repertoire of regulatory molecules (5).
A basic model of S. aureus pathogenesis has virulence progressing in two discrete stages. The first stage is typified by the
production of adhesins and surface proteins during the exponential phase of growth. The second stage of infection, analogous to the post-exponential and stationary phases of growth in
vitro, is characterized by increased toxin production, which
leads to increased tissue damage and bacterial spread. The
regulatory events controlling this phenotypic switch center on
the activities of the agr quorum-sensing system, which represses the expression of surface proteins, including protein A
(spa), and upregulates the production of toxins, such as ␣-hemolysin (hla) and V8 protease (sspA), in transition from late
exponential to post-exponential phases (22).
The agr system is comprised of two divergent transcripts,
RNAII and RNAIII. RNAII carries four genes, agrDBCA,
which are dedicated to the synthesis, sensing, and processing of
the quorum-sensing autoinducing peptide (AIP) required for
the activation of the RNAII promoter, primarily during the
late exponential phase. The divergent transcript RNAIII, activated in response to RNAII via AgrA, is a regulatory RNA
molecule expressed maximally during the post-exponential
phase and controls virulence gene expression at the transcriptional and translational levels, the latter via an antisense mechanism (11). A number of regulators controlling agr expression

MATERIALS AND METHODS
Reagents, bacterial strains, and growth conditions. Unless specified otherwise, all reagents were obtained from either Fisher (Pittsburgh, PA) or Sigma
(St. Louis, MO). The bacterial strains used in this study are listed in Table 1.
Escherichia coli strains were routinely grown on Luria-Bertani (LB) broth or agar
containing 100 g/ml of ampicillin where appropriate. S. aureus cultures were
routinely cultured on either tryptic soy broth or agar. Strains carrying plasmids
were selected and maintained on either 2.5 g/ml erythromycin or 10 g/ml
chloramphenicol, as appropriate. Experiments investigating agr transcription
were carried out in 03GL broth (23).
Cultures for gene and protein expression analysis were grown in either glass
sidearm flasks or 18-mm glass tubes in an Excella E24 shaking incubator set at
37°C and 250 rpm (New Brunswick Scientific, Edison, NJ). Growth was monitored by determining culture turbidity at 650 nm with an 18-mm borosilicate glass
tube using a Spectronic 20D⫹ spectrophotometer (Spectronic Analytical Instruments, Garforth, England). Data collected at mid-, late, or post-exponential
phases of growth corresponded to turbidity readings of 0.7, 1.1, and 1.7, respectively.
Genetic manipulations. A list of oligonucleotides used in this study is available
from the authors. Enzymes and reagents used for genetic manipulations were
obtained from either Invitrogen (Irving, CA) or New England Biolabs (Ipswich,
MA) and used according to the manufacturers’ recommendations. Plasmids were
originally propagated in E. coli and transformed by electroporation into RN4220,
a heavily mutagenized, restriction-deficient strain of S. aureus capable of methylating foreign DNA. The methylated plasmid DNA was then electroporated into
the appropriate S. aureus strains. All positive clones were initially identified by
PCR and confirmed by DNA sequencing.
A markerless, in-frame deletion of rsr was constructed in four S. aureus strains
using a PCR-based splicing technique followed by splicing overlap extension
(SOEing), as described previously (2, 26). Briefly, the fragment was cloned into
pMAD and introduced into S. aureus strains SH1000, Newman, RN6390, and
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TABLE 1. Bacterial strains and plasmids used in this study
Strain or
plasmid

Description

Reference

S. aureus
RN4220
SH1000
COL
Newman
RN6390
ALC4657
ALC4658
ALC4659
ALC4660
ALC6582
ALC6583
ALC6584
ALC2386
ALC6585
ALC6586

Heavily mutagenized strain that accepts foreign DNA, agr mutant
8325-4 with rsbU restored
A methicillin-resistant strain, isolated from a human infection in the early 1960s
Methicillin-sensitive laboratory strain, isolated from a human infection in 1952
Laboratory strain related to strain 8325-4
SH1000 ⌬rsr
COL ⌬rsr
Newman ⌬rsr
RN6390 ⌬rsr
SH1000 ⌬rsr/rsr complement
SH1000 ⌬sarR
SH1000 ⌬sarR ⌬rsr
SH1000 agr::tetM
SH1000 agr::tetM ⌬rsr
SH1000 with pEPSA5::rsr

23
14
13
3
25
This
This
This
This
This
This
This
14
This
This

E. coli
TOP10

General cloning strain

Invitrogen

E. coli-S. aureus shuttle vector containing a thermosensitive origin of replication bgaB, Emr, Apr
E. coli-S. aureus shuttle vector containing a xylose-inducible promoter, Apr, Cmr
E. coli-S. aureus shuttle vector derived from pSK236 containing a multiple cloning site upstream of the
gfpuvr gene (a gfp variant optimized for expression in S. aureus), Apr, Cmr
agr P3 promoter driving the expression of gfpuvr in pALC1484
spa promoter driving the expression of gfpuvr in pALC1484
hla promoter driving the expression of gfpuvr in pALC1484
sspA promoter driving the expression of gfpuvr in pALC1484

2
9
16

Plasmids
pMAD
pEPSA5
pALC1484
pALC1743
pALC1741
pALC1740
pALC2831

COL (to obtain rsr) or ALC2386 (to obtain the rsr-agr mutant in SH1000) by
electroporation, followed by the selection of blue colonies. Transformants were
grown at 42°C, a nonpermissive temperature for pMAD replication, and then at
30°C to drive homologous recombination to yield white colonies (2, 26). A
similar approach was used to construct the rsr-sarR double mutant in the SH1000
background, using primers flanking both sarR and rsr.
The mutation in the rsr mutant was restored by cloning the wild-type gene into
pMAD and reintroducing it into the chromosome by homologous recombination, as described above. The rsr-overproducing strain was creating by cloning the
rsr open reading frame behind the xylose-inducible promoter of the plasmid
pEPSA5 (9).
Transcriptional analysis by Northern blotting. Cells from either the mid-, late,
or post-exponential phases of growth were harvested, resuspended in Trizol
(Invitrogen), and lysed using 0.1-mm silica-zirconia beads in a reciprocating
shaker. The RNA was extracted and resuspended in diethyl pyrocarbonate
(DEPC)-treated water, according to the manufacturer’s instructions. Ten micrograms of RNA was separated electrophoretically on 1.5% agarose-0.66 M formaldehyde gels in MOPS buffer (20 mM morpholinepropanesulfonic acid, 10 mM
sodium acetate, 2 mM EDTA [pH 7]), transferred onto a Hybond XL nylon
membrane (GE Healthcare) in 20⫻ SSC (3 M NaCl, 0.3 M sodium citrate [pH
7]), and fixed to the membrane by cross-linking in a Stratalinker 1800 (Stratagene, La Jolla, CA).
The DNA probes, generated by either PCR or restriction digestion, were
labeled with [␣-32P]dCTP using the Roche random prime labeling kit (Hoffmann-La Roche Inc., Nutley, NJ) and added to the nylon membranes at 65°C.
After hybridization overnight, the membranes were washed extensively and
autoradiographed. Blots shown in Fig. 1, 2, 3, and 6 are representative of
results from three separate experiments, and the intensities of the resulting
bands were quantified using ImageJ (1).
Real-time PCR analysis of gene transcription. RNA, prepared as described
above, was treated with RNase-free DNase to remove residual DNA, according
to the manufacturer’s instructions (Turbo-DNAfree; Applied Biosystems/Ambion, Austin, TX). Successful removal of the DNA was confirmed by PCR
analysis. RNA (1 g) was reverse transcribed using the Roche Transcriptor
first-strand cDNA synthesis kit, and the resulting cDNA levels were quantified
using the Maxima SYBR kit from Fermentas (Glen Burnie, MD) in a Roche

work
work
work
work
work
work
work
work
work

16
17
17
26

LightCycler 1.5 according to the manufacturer’s protocols. Reported levels of
gene expression were normalized to those of gyrB.
Detection of SarR and Rsr by Western blotting. Post-exponential-phase (optical density at 650 nm [OD650] of 1.7) or late-exponential-phase (OD650 of 1.1)
cells were collected and lysed in 10 mM Tris, 1 mM EDTA (pH 8) with 0.1-mm
silica-zirconia beads in a reciprocating shaker. Soluble cellular proteins were
separated from debris by a high-speed spin at 12,000 ⫻ g for 5 min at 4°C and
quantified using the BCA protein assay kit (Fisher). Equal amounts (20 or 75 g)
of protein were then separated on a 12.5% polyacrylamide-SDS gel and transferred onto a polyvinylidene difluoride membrane. The presence of SarR or Rsr
was detected on the membranes using standard Western blotting procedures.
The primary antibody was a murine-derived anti-SarR monoclonal antibody
(clone 1D1) or murine anti-Rsr polyclonal antibody used at a concentration of
1:1,000, and the secondary antibody was donkey-derived anti-mouse immunoglobulin G conjugated with horseradish peroxidase (Jackson ImmunoResearch
Laboratories, West Grove, PA) and used at a concentration of 1:10,000. After a
series of extensive washes, an enhanced chemiluminescence kit (GE Healthcare)
was used to detect binding of the antibodies to the membrane. Where applicable,
ImageJ was used to quantify the relative intensities of the resulting bands.
Results shown are representative of three separate experiments.
Transcriptional analysis using green fluorescent protein (GFP)-promoter fusions. Shuttle plasmids containing the promoter regions of various genes (Table
1) driving the expression of GFPuvr (16) were transformed into SH1000, the rsr
mutant, and the complemented mutant by electroporation. The resulting strains
were grown overnight in tryptic soy broth (TSB), diluted 1:100 in fresh TSB the
next morning, and incubated at 37°C with shaking at 250 rpm. Growth (OD600)
and fluorescence (excitation/emission of 485/515 nm) of the cultures were monitored with an FL600 microplate fluorescence reader (BioTek Instruments, Winooski, VT). Experiments were performed three times using four independently
isolated clones in triplicate. Error bars represent the standard errors of the
means, and statistical significance was determined by the Student t test.
Subcutaneous murine model of skin infection. SH1000 and its isogenic rsr
mutant were grown in TSB to post-exponential phase (OD650 of 1.7), harvested,
washed three times in sterile saline, and resuspended in sterile saline at 109
CFU/ml. CFU (108) in 100 l of SH100 or the rsr mutant were injected subcutaneously into the shaved backs of six 12-week-old male C57BL/6 mice in the
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SH1000 group or in the rsr mutant group (Jackson Labs, Bar Harbor, ME). One
mouse from the SH1000 group died upon handling. The mice were then monitored daily for subcutaneous abscess formation and other changes in general
appearance (e.g., ruffled hair and activity). On the 8th day postinfection, the mice
were sacrificed and 8-mm punch biopsy specimens of the skin were obtained
from the infected sites. A portion of the skin biopsy specimen was fixed in 10%
neutral buffered formalin for histological analysis; the remainder was processed
in a glass tissue grinder and serially diluted to determine bacterial counts. Results
reported are the means relative to the mass of the tissue section in grams.
Statistical significance was determined using the Student t test.
Samples for histology were embedded in paraffin, sectioned at 5 m, and
stained with hematoxylin and eosin according to standard histological procedures. Slides were viewed and images were captured using an Olympus digital
light microscope (Olympus America Inc., Center Valley, PA).

RESULTS
Identification of rsr. Recent complementation studies of the
sarR mutant from our lab suggested that the genetic locus
upstream of sarR may inhibit sarR expression. We have termed
this locus rsr, for repressor of sarR. rsr is a unique gene bearing
no homology to any gene outside the staphylococci, nor does it
have any conserved motifs or domains. It is predicted to encode a 108-amino-acid protein with a molecular mass of ⬃12.5
kDa and a theoretical pI of 4.54.
The rsr locus neighbors other regulatory genes (Fig. 1A).
Besides being upstream of sarR, rsr is also directly downstream
of sarY, another member of the SarA protein family (5, 6). An
uncharacterized gene, SA2092, lies upstream of sarY and is
homologous to the AraC family of regulators. Despite its proximity to these regulatory genes, rsr appeared to be transcribed
monocistronically with a transcript size of ⬃400 nucleotides
(nt), corresponding to the size of the rsr gene plus the intergenic region at the 5⬘ end (Fig. 1A and B). Analysis of rsr
expression during different phases of S. aureus growth revealed
that the gene was most highly transcribed during mid-exponential phase; however, the levels of the Rsr protein produced
appeared to be stable throughout the growth period (Fig. 1B).
To investigate the phenotypic and genotypic effects of rsr, we
first constructed an in-frame deletion of rsr in S. aureus strain
SH1000, chosen for its similarity to the commonly published
strains, including 8325-4 and RN6390, and its possession of an
intact rsbU gene within the stress-induced sigB operon. As
expected, the rsr mutant of SH1000 did not express the cognate
transcript, while restoration of a single copy of rsr to the mutant chromosome reestablished the transcription of rsr (Fig.
1C). Immunoblot analysis demonstrated that the Rsr protein
was absent in the rsr mutant but was expressed in the parent
SH1000 strain and the restored rsr mutant strain (Fig. 1D).
Repression of SarR by rsr. As described above, we initially
suspected that rsr, a gene adjacent to sarR, may be a repressor
of SarR expression in S. aureus. To verify the impact of rsr on
sarR expression in a variety of prototypic S. aureus strains,
including SH1000, we also deleted rsr in RN6390, Newman,
and COL, thus encompassing both methicillin-susceptible
(MSSA) and methicillin-resistant S. aureus (MRSA) strains.
Lysates of rsr mutants from strains SH1000, RN6390, Newman,
and COL prepared from post-exponential-phase cells (corresponding to the peak expression period for sarR) were immunoblotted and probed with an anti-SarR monoclonal antibody.
In all four genetic backgrounds, expression of the SarR protein
was increased in the mutant compared to that in the cognate

FIG. 1. (A) Genomic context of the rsr gene. rsr lies in close proximity to three regulatory genes, sarR, sarY, and SA2092, which encodes
a gene product with similarity to the AraC protein family. (B) Transcription (top) of rsr during the early, mid-, and late exponential phases
of growth in strain SH1000. Numbers underneath the panels indicate
relative intensities of the bands as determined by ImageJ. rRNA bands
(middle) are shown as a loading control for the top panel. (C) Transcription (top) of rsr during the mid-exponential phase in the SH1000
parent, rsr mutant, and restored rsr mutant with a single copy of the rsr
gene at its native chromosomal location. The intensities of the rRNA
bands (bottom) serve as loading controls. (D) Translation of Rsr in the
parent, mutant, and restored rsr mutant strains at late exponential
phase as detected by a Western blot, with 20 g of whole-cell lysate
each and probed with a 1:1,000 dilution of murine anti-Rsr antibody
(top). The bottom panel represents an equivalent SDS gel stained with
Coomassie blue to demonstrate comparable loading among the lanes.

parent, ranging from an ⬃20% increase in the Newman mutant to ⬃60% in the RN6390 mutant compared with the corresponding parent, thus demonstrating the repressive effect of
rsr on SarR in a variety of strains (Fig. 2A). Based on these
trends, we decided to focus on SH1000, predicated upon the
wealth of information we and others have generated on the
regulatory pathway of agr and sarA in this strain (15, 20, 21,
29). Using the rsr mutant and the restored rsr mutant in which
the mutated gene was replaced by the wild-type copy, we analyzed sarR transcription and showed that the sarR transcript
level was increased in the rsr mutant compared with that in the
cognate parent SH1000 strain but returned to the parental

VOL. 78, 2010

FIG. 2. Effect of an rsr mutation on the translation (A) and transcription (B) of sarR. (A) Western blot analysis of SarR expression in
rsr mutations in four S. aureus strains. Cell lysates were prepared from
late-exponential-phase cells and probed with a murine anti-SarR
monoclonal antibody. Expression of the SarR protein in the rsr mutants was 1.4, 1.6, 1.2, and 1.5 times that of the respective parents in
SH1000, RN6390, Newman, and COL, as determined by ImageJ. (B)
Northern blot analysis of sarR transcription during the late exponential
growth phase in the SH1000 parent, the rsr mutant (expression at 1.7
times that of SH1000), and the restored rsr mutant. rRNA bands are
shown as loading controls.

level in the restored rsr mutant, strongly suggesting that rsr was
repressing sarR expression (Fig. 2B).
Role of rsr in virulence gene transcription. Given the role of
agr and sarA in modulating expression of many virulence genes
(19, 21), we next examined the transcript levels of these two
regulatory loci in the rsr mutant compared to those in the
parent SH1000 strain and the restored rsr mutant strain. Curiously, the levels of sarA transcription were virtually identical
among all 3 strains (data not shown), thus implying that rsr
does not play a major role in controlling sarA expression. We
then assessed agr expression by ascertaining the levels of
RNAII (carrying the machinery of the agr system, agrDBCA),
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normally expressed maximally during the late exponential
phase (OD650 of 1.1). As shown in Fig. 3A, the transcription of
RNAII was significantly increased in the rsr mutant compared
to that in the parent and the restored rsr mutant. As RNAII
augments RNAIII (the agr effector regulatory molecule), we
also found that RNAIII expression was elevated in the rsr
mutant compared to that in the cognate parent and restored
mutant (Fig. 3A). GFP fusion analysis of the agr RNAIII
promoter confirmed the Northern blot data (Fig. 3B). We also
examined the expression of virulence genes controlled by agr.
More specifically, the transcription of hla (encoding ␣-hemolysin), sspA (encoding V8 protease), and spa (encoding protein
A) was also affected upon deletion of rsr, with both hla and
sspA transcription upregulated by 2- to 3-fold in the rsr mutant
compared to the that in the parent and the restored rsr mutant,
as assessed by Northern blot and promoter fusion analyses
(Fig. 3A, C, and D). In contrast, the transcription of spa was
downregulated in the rsr mutant compared to that in the parent
and the restored rsr mutant (Fig. 3A and E). The upregulation
of hla and sspA and the downregulation of spa in the rsr mutant
of SH1000 is in concordance with upregulation of RNAII and
RNAIII in this strain.
Ascertaining the linkage between rsr and agr. Based on the
above transcriptional data, we wanted to determine if rsr requires SarR to impact agr and the ensuing downstream genes,
such as hla, sspA, and spa. For this purpose, we first constructed an in-frame deletion mutant of both sarR and rsr to
determine the role of sarR in mediating the effect of rsr on agr.
Cognizant of the fact that the agr effector molecule RNAIII is
maximally expressed during the post-exponential phase
(OD650 of 1.7), we used real-time PCR transcription of
RNAIII in the rsr-sarR double mutant during this growth

FIG. 3. Effect of an rsr mutation on agr RNAII and RNAIII, hla, sspA, and spa transcript levels (A) and promoter activities (B to E).
(A) Northern blot analysis of RNA isolated from postexponential-phase (RNAII, RNAIII, hla, and sspA) or late-exponential-phase (spa) cells.
Late exponential and postexponential phases are defined as an OD650 of 1.1 and 1.7, respectively, using 18-mm borosilicate glass tubes in a
Spectronic 20D⫹ spectrophotometer. (B to E) GFP-promoter fusion analysis of the agrP3, hla, sspA, and spa promoter activities, respectively, over
the course of bacterial growth in the SH1000, rsr mutant, and restored rsr mutant strains. ⴱ, P ⬍ 0.01, as determined by the Student t test.

4388

TAMBER ET AL.

INFECT. IMMUN.

FIG. 4. (A) Transcriptional analysis of RNAIII, hla, sspA, and spa in an rsr-sarR and an rsr-agr double mutant from post-exponential-phase cells
(OD650 of 1.7), treated with RNase-free DNase, reverse transcribed into cDNA, and analyzed by real-time PCR. (B) Real time-PCR of RNAIII
of late-exponential-phase cells (OD650 of 1.1) from rsr, sarR, sarR-agr, and rsr-sarR mutants. Transcription levels in the mutants are normalized to
the levels of gyrB and are reported relative to their transcription in the SH1000 parent (set to 1). The error bars represent individual standard
deviations. The P values for SH1000 compared to the single rsr mutant, sarR mutants, and double mutants are ⬍0.0008, ⬍0.02, and ⬍0.0006,
respectively. The P values for the rsr-sarR double mutant compared to the rsr single mutant and the sarR mutant are ⬍0.005 and ⬍0.008,
respectively.

phase. As shown in Fig. 4A (top left), the transcription of
RNAIII was more pronounced in the double rsr-sarR mutant
than in the rsr single mutant by a factor of 3.5 and in the parent
SH1000 by a factor of 6.7. As expected, the transcription of hla
in the rsr and rsr-sarR mutants was increased compared with
that in the parental SH1000 strain. However, hla expression in
the rsr mutant was 1.3-fold higher than in the double rsr-sarR
mutant (Fig. 4A, top right). With respect to sspA and spa
transcription, the rsr-sarR double mutant demonstrated a phenotype consistent with a higher level of RNAIII than the single
rsr mutant, with sspA transcript levels increased by 1.3-fold and
spa transcription significantly decreased in the double mutant
compared to that in the rsr single mutant (Fig. 4A, bottom).

We also analyzed the effect of rsr on RNAIII during the late
exponential phase (OD650 of 1.1). Similar to the findings during the post-exponential phase, the double rsr-sarR mutant
exhibited a higher level of RNAIII expression than either the
single rsr or the sarR mutant, as assessed by real-time PCR
(Fig. 4B). More importantly, both rsr and sarR mutants demonstrated higher RNAIII expression than the parental SH1000
strain. Based on the above data with RNAIII, sspA, and spa,
our results suggested that agr and its downstream effectors are
repressed by rsr. This repressive effect of rsr is likely independent of sarR, because RNAIII expression is higher in the rsrsarR double mutant than in the single rsr and sarR mutants.
To determine if the virulence genes controlled by rsr are

VOL. 78, 2010
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FIG. 6. rsr as an inhibitor of virulence gene regulators. The rsr gene
was overexpressed in SH1000 using a multicopy plasmid pEPSA5 containing rsr, and the transcript levels of rsr and agr RNAIII were assessed by Northern blotting using RNA extracted from post-exponential-phase cells (OD650 of 1.7). The expression of rsr and RNAIII in the
rsr mutant expressing a high copy number of rsr was 4 times and 0.2
times that of the parental SH1000 strain, using ImageJ to determine
the relative band intensities.

FIG. 5. Virulence of the rsr mutant. (A) A group of six C57BL/6
mice were each injected subcutaneously with 108 CFU of parent
SH1000 or the rsr mutant and monitored daily. Eight days postinfection, the mice were sacrificed, and punch biopsies of the skin were
done to determine bacterial load (ⴱ, P ⬍ 0.01, as determined by the
Student t test) and to examine any histological differences between the
mice from the parental SH1000 group (left) and the rsr mutant group
(right). (B) Top, low magnification (100⫻) of the dermal and subdermal layers. Note the absence of the dermal layer and subcellular
structures (ⴱ) in the biopsy specimen taken from a mouse infected with
the rsr mutant and the presence of clusters of bacteria (arrows). Bottom, higher magnification (1,000⫻) of a representative bacterial cluster (right, arrow) present in the rsr mutant-infected tissue (right) and
an equivalent region from the SH1000-infected tissue (left).

totally dependent on agr repression, we constructed an rsr-agr
double mutant, followed by transcriptional analysis of virulence genes in this strain by real-time PCR. In contrast to the
rsr-sarR double mutant, the transcriptional patterns of the rsragr double mutant differed significantly from that of the single
rsr mutant, with both hla and sspA transcription markedly reduced (over 50% reduction) compared to that in the parental
strain, while spa transcription was almost fully restored to the
parental level (Fig. 4A), again reaffirming the notion that the
regulation of these effector genes by rsr is mediated via RNAIII
of the agr locus (Fig. 4A).
Hypervirulence of an rsr mutant. Based on the transcriptional profile of increased agr transcription in the rsr mutant,
we reasoned that the mutant might be hypervirulent compared with the parent. To test this hypothesis, we employed
a murine model of cutaneous infection. For this model, we
injected 108 CFU/100 l of SH1000 or the rsr mutant subcutaneously into the shaved backs of 6- to 12-week-old male
C57BL/6 mice. On the first day postinfection, all of the mice
in the mutant group had developed small areas of redness
near the injection site, whereas none of the mice in the

parental SH1000 group did. As the infection progressed, the
mice infected with SH1000 did eventually develop small, red
lesions on their backs that were indistinguishable from those
of the mice in the rsr mutant group. The bacterial loads
recovered from the tissue biopsy specimens were markedly
different between the two groups of mice. On average, 83
and 32,500 CFU/gram of tissues were recovered from the
mice in the SH1000 and rsr groups, respectively (Fig. 5A).
The histological profile of the tissue sections taken from the
mice reflected their bacterial burden. Skin tissue samples
taken from the mice infected with SH1000 had normal skin
architecture with increased infiltration of phagocytic cells in
the dermis (Fig. 5B, left) and a lack of tissue necrosis.
Importantly, few, if any, bacteria were present in the infected tissue. Mice infected with the rsr mutant, in contrast,
revealed abnormal skin histology; in particular, there was a
massive infiltration of neutrophils and monocytes to the
dermal and subdermal layers (Fig. 5B, right). The epidermal
layer was absent, and several subcutaneous structures, such
as hair shafts and sebaceous glands, were obliterated. Additionally, large clusters of bacteria were visible in the deep
muscle tissue (Fig. 5B, bottom right).
rsr as an inhibitor of agr. Both transcriptional analysis of
virulence genes and the results obtained from the murine
model of cutaneous infection suggested that the rsr mutant
possessed an increased virulence phenotype. We thus considered the possibility that provision of rsr in multiple copies
to S. aureus may decrease its virulence properties. To test
this hypothesis, rsr was cloned downstream of the xyloseinducible promoter of the pEPSA5 plasmid and transformed
into strain SH1000. The levels of rsr and RNAIII transcription were then assessed in the resultant strain, the rsr⫹⫹
strain. As shown in Fig. 6, the level of rsr transcription was
approximately 4-fold higher in rsr⫹⫹ than in SH1000. The
increased gene dosage of rsr in the rsr⫹⫹ strain resulted in a
dramatic reduction (⬃80%) in agr RNAIII transcription
compared with that in SH1000.
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DISCUSSION
In this study, we report the identification of rsr, a gene
unique to the staphylococci that bears no similarity to any
known gene or conserved domain. Inactivation of rsr, residing
in a chromosomal location directly adjacent to sarR, resulted in
overproduction of the virulence gene regulator SarR in four S.
aureus strains. Using SH1000 as the genetic backdrop, we
found that the rsr mutant also exhibited augmented agr
(RNAII and RNAIII), hla (␣-hemolysin), and sspA (V8 protease) transcription as well as a decrease in the spa (protein A)
transcript level, consistent with an increase in agr expression in
the rsr mutant. As SarA is a positive regulator of agr, we also
analyzed sarA transcription in the rsr mutant of S. aureus strain
SH1000 and found comparable levels of sarA transcription
among the mutant, parent, and rsr-restored mutant strains.
The rsr gene was transcribed most highly during the midexponential phase of growth; however, analysis of Rsr suggested that the protein level was relatively constant throughout
the growth cycle. This observation suggested that the Rsr protein may not be involved in the temporal control of gene
expression unlike several other S. aureus regulatory loci but
may act throughout the growth cycle (4, 5). Indeed, changes in
activity of both the agr and spa promoters, which exhibited the
most striking changes in the rsr mutant, were sustained over
the entire growth cycle (Fig. 3B and D). On the other hand, the
promoter activities of hla and sspA, which are most active after
the exponential phase, remained subdued in the mutant until
the cells reached post-exponential phase (Fig. 3C and D), at
which time these promoters became much more active than
those in the parent, suggesting that regulatory factors other
than rsr may have been at play in controlling these genes.
Although rsr is a repressor of sarR (Fig. 2) and agr (Fig. 3),
we found that increased agr RNAIII expression in the rsr mutant is not attributable to enhanced sarR expression, because
RNAIII expression in the double rsr-sarR mutant was higher
than that in the single rsr and sarR mutants (Fig. 4B). More
specifically, analysis of agr expression in the rsr-sarR double
mutant indicated that the derepressive effects of rsr and sarR
mutations on agr RNAII and subsequently on RNAIII appear
to be additive (e.g., compare the RNAIII expression in rsr,
sarR, and double rsr-sarR mutants in Fig. 4B). Consistent with
this result was the observation that the effects of concomitant
rsr and sarR mutations in SH1000 on sspA and spa expression
also appeared to be culminative (Fig. 4A). These results indicated that either rsr directly represses agr transcription or does
so via another regulatory molecule which acts as an intermediary between rsr and agr. In addition, the effect of rsr on agr
expression is independent of SarR. The finding that the introduction of an agr mutation in an rsr mutant can downregulate
hla and sspA as well as upregulate spa expression to near
parental levels (Fig. 4) could lend support to the notion that rsr
regulates virulence determinants primarily via an intact agr
pathway (Fig. 7).
The transcriptional changes observed in the rsr mutant implied that its virulence phenotype may also have been enhanced. These phenotypic changes, however, were difficult to
assess in SH1000 because this strain, by virtue of the restored
rsbU gene, displays an enhanced sigB response and hence a
more muted agr response (14), resulting in very low levels of

FIG. 7. Proposed mechanism of rsr-mediated gene regulation. rsr
represses both sarR and agr during the late exponential phase. The
repressive effects on agr by rsr during the late exponential phase are
shown with regard to hla, sspA, and spa transcription. It is unclear
whether rsr represses agr directly or via an as-of-yet-unidentified regulator. The repression of agr contributes to the repression of both hla
and sspA and to the activation of spa. Together, these regulatory
changes are predicted to result in a net decrease in virulence. The
genetic locus rsr thus acts independently of SarR to inhibit agr expression.

hemolysis and proteolysis activities in vitro. We therefore decided to evaluate the clinical significance of rsr in vivo by
comparing the virulence properties of the parent and mutant
strains in a murine model of cutaneous infection. As expected,
SH1000 was not proficient in causing subcutaneous abscesses
in the mouse model, requiring up to 108 CFU to establish a
mild abscess in the parent group. With the exception of a few
erythematous lesions, most of the mice seemed unaffected
initially by the subcutaneous injection of 108 CFU of strain
SH1000. Histological studies also disclosed the integrity of the
epidermis and dermis layers of the skin, thus corroborating
with the clinical observation of these mice, which appeared
relatively healthy. In contrast, subcutaneous injection of an
equivalent dose of the rsr mutant offered dramatically different
results, with on average almost 100-fold more bacteria recovered from the injection sites of the rsr group than from those of
the parental group. Histological findings of mice infected with
the rsr mutant also bore several classical hallmarks of infection/
inflammation, with disruption of the epidermis accompanied
by massive neutrophilic infiltration of the dermis layer.
Accordingly, this work extends our knowledge of the regulatory cascade controlling virulence in S. aureus. Our studies
have identified rsr as the first known regulator of sarR. Besides
repressing sarR expression, rsr also downregulates agr transcription. This reduction in agr expression was not due to
changes in sarA expression. In addition, both rsr and SarR
appear to repress agr expression in an additive manner during
the late exponential phase, as exemplified by enhanced RNAII
and RNAIII expression in the double rsr-sarR mutant over the
single rsr and sarR mutants (Fig. 4). Whether the rsr-mediated
effect on agr during the late exponential phase is direct or
indirect via another regulator remains to be defined. However,
we cannot directly infer from our studies here the role of rsr on
stationary-phase expression of virulence determinants, because
we have found that heightened expression of RNAIII during
the stationary phase is less dependent on rsr (unpublished
data). Nevertheless, it is clear that a mutation in rsr has led to
an enhanced virulence response in our murine cutaneous
model. Indeed, overexpression of rsr in the parental SH1000
strain, as expected, decreased the transcription of RNAIII of
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agr, and consequently, one would predict a corresponding decrease in virulence effectors and hence disease progression if
rsr is upregulated in vivo.
One relevant question regarding our findings is the plausible
mechanism by which a unique molecule like rsr, which is
present only in staphylococcal species, could inhibit expression
of agr-controlled virulence determinants. We have found that
the Rsr protein does not bind to the agr promoter, thus ruling
out direct protein-DNA binding as a mode of regulation. Additionally, pulldown studies showed that Rsr and SarR do not
interact at the protein-protein level. Interestingly, model analysis of S. aureus mRNA structure revealed that the ⬃400-nt rsr
mRNA has features consistent with a small antisense RNA
(12, 24). This mRNA, which is transcribed most highly during
mid-exponential growth, may then regulate the target gene
function early during the growth cycle. Work is ongoing to
investigate this possibility.
Additional work in our lab is directed at determining
whether these regulatory pathways are found in more clinically
relevant strains, such as the community-acquired strains
USA300 and USA400. If so, developing the means to either
increase the levels of rsr or augment its activities may lead to
the development of novel anti-infectives toward S. aureus.
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